PRELIMINARY PROGRAMME

CONGRESS THEME: “Hospital Pharmacy and Economy”

An important characteristic of every system of healthcare provision is that there exists in principle an endless demand of care versus limited resources. If one looks at the component of pharmaceuticals, this feature is even more prominent. Moreover, the ongoing introduction of new and more sophisticated drugs are likely to result in disproportionate claims on the healthcare budget. On average some 10% of a national drug-budget is being spent in the hospital, with hospital pharmacists in charge of acquisition and dispensing. The demand for more resources will increase because:
- the average life expectancy in Europe will increase;
- the increase of costs due to the introduction of new technologies
- the increased appreciation of health and healthcare provision by European citizens.

We expect that the hospital pharmacist needs more and more economic and financial managerial skills to be able to bear the responsibility for the ever increasing drug-budgets in hospitals. For this reason, the Scientific Committee of the EAHP Congress has chosen economy in relation with hospital pharmacy as the theme for its 10th annual congress.

PROGRAMME

WEDNESDAY 16 MARCH 2005

14.00-15.30: Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 1, Cost-effectiveness of drug treatment
Level: Introductory
A. Costing issues in cost-effectiveness analysis
Speaker: Kjeld Møller Pedersen (Denmark)
B.A simple evaluation of cost-effectiveness using the tools of EBM
Speaker: Roberto Frontini (Germany)
C. Are cost-effectiveness studies good enough?
Speaker: Kjeld Møller Pedersen (Denmark)

Seminar 4, Too many clowns not enough circuses: How to grow clinical pharmacy and keep adding value / Level: Intermediate
A. Introduction
Speaker: Michael Cross (United Kingdom)
B. Experience from the United Kingdom
Speaker: Tony West (United Kingdom)
C. Experience from outside the United Kingdom
Speaker: Jose Feio (Portugal)

Seminar 6, Do pharmacogenomics and pharmaco-genetics fulfil their promise? / Level: Advanced
A. How can genetics help us develop new treatments?
Speaker: Hugh E. Montgomery (United Kingdom)
B. Validated evidence for better treatment outcomes is scarce
Speaker: John P. Ioannidis (Greece)

15.30-16.00: Coffee break

16.00-17.30: Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 3, The need for pharmaco-economy guidelines
Level: Advanced
A. The policies behind pharmaco-economy guidelines
Speaker: Louis Niessen (The Netherlands)
B. The practice of applying these guidelines
Speaker: Alec Miners (United Kingdom)

Seminar 9, The new EU 2001/20 clinical trial directive affects your pharmacy too! / Level: Advanced
A. Why do we have a new directive and what does it mean?
Speaker: Joao Oliveira (Portugal)
B. Will clinical trials still be possible in my hospital?
Speaker: Dorothea Schimpf (Germany)

Seminar 10, Medication error reporting in Europe
Level: Introductory
A. What every medication error reporting system needs: uniform classification
Speaker: Patricia van den Bemt (The Netherlands)
B. European initiatives for improving medication safety
Speaker: David Cousins (UK)
C. Medication error reporting: the experience in the USA
Speaker: Allen Vaida (USA)
18.00-20.00: Opening Ceremony
Anniversary Keynote
Speaker: Jochen Kotwas (Germany)
Keynote presentation 'Drug cost and reimbursement'
Speaker: Vassilis Kontozamanis (Greece)

20.00-21.00: Welcome reception and opening of the exhibition
THURSDAY 17 MARCH 2005

09.00-10.30: Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 2, How clinical decisions are influenced by economical factors / Level: Intermediate
A. The role of hospital pharmacist in clinical practice with respect to pharmacotherapy
B. The role of pharmacists in hospital pharmacy practice in the area of pharmacoecomics
Speaker: Lenka Praznovcova (Czech Republic)

Seminar 5, Orphan drug systems in the EU / Level: Intermediate
A. Orphan drug legislation in Europe
Speaker: Veijo Saano (Finland)
B. Ethical and commercial aspects of Orphan Drugs
Speaker: Harrie Seeverens (The Netherlands)

Seminar 6, Do pharmacogenomics and pharmacogenetics fulfil their promise? / Level: Advanced
A. How can genetics help us develop new treatments?
Speaker: Hugh E. Montgomery (United Kingdom)
B. Validated evidence for better treatment outcomes is scarce
Speaker: John P. Ioannidis (Greece)

10.30-11.30: Coffee break and attended posters

11.30-12.30: Keynote presentation
Practical implications of disaster preparedness for a Hospital
Speakers: Ana Herranz (Spain) & Pilar Gomez (Spain)

12.30-14.00 Lunch

14.00-15.30: Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 3, The need for pharmaco-economy guidelines
Level: Advanced
A. The policies behind pharmaco-economy guidelines
Speaker: Louis Niessen (The Netherlands)
B. The practice of applying these guidelines
Speaker: Alec Miners (United Kingdom)

Seminar 4, Too many clowns not enough circuses: How to grow clinical pharmacy and keep adding value / Level: Intermediate
A. Introduction
Speaker: Michael Cross (United Kingdom)
B. Experience from the United Kingdom
Speaker: Tony West (United Kingdom)
C. Experience from outside the United Kingdom
Speaker: Jose Feio (Portugal)

Seminar 7, Information and communication technology and automation of logistics / Level: Advanced
A. System analysis: where to focus with ICT technology
Speaker: Mark Neuenschwander (USA)
B. Practical solutions anno 2005
Speaker: Hadewig Colen (The Netherlands)

Seminar 10, Medication error reporting in Europe
Level: Introductory
A. What every medication error reporting system needs: uniform classification
Speaker: Patricia van den Bemt (The Netherlands)
B. European initiatives for improving medication safety
Speaker: David Cousins (UK)
C. Medication error reporting: the experience in the USA
Speaker: Allen Vaida (USA)

15.30-16.00: Coffee break

16.00-17.30: Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 1, Cost-effectiveness of drug treatment
Level: Introductory
A. Costing issues in cost-effectiveness analysis
Speaker: Kjeld Møller Pedersen (Denmark)
B.A simple evaluation of cost-effectiveness using the tools of EBM
Speaker: Roberto Frontini (Germany)
C. Are cost-effectiveness studies good enough?
Speaker: Kjeld Møller Pedersen (Denmark)

Seminar 8, Prescribing drugs: should it always be a medical doctor? / Level: Introductory
A. Legal, ethical and professional aspects of supplementary pharmacy prescribing
Speaker: David Gerrret (United Kingdom)
B. Training for non-doctors prescribers
Speaker: David Webb (United Kingdom)

Seminar 9, The new EU 2001/20 clinical trial directive affects your pharmacy too! / Level: Advanced
A. Why do we have a new directive and what does it mean?
Speaker: Joao Oliveira (Portugal)
B. Will clinical trials still be possible in my hospital?
Speaker: Dorothea Schimpf (Germany)

FRIDAY 18 MARCH 2005

09.00-10.30: Scientific and Practice sessions and Industry-sponsored satellite symposia

Seminar 2, How clinical decisions are influenced by economical factors / Level: Intermediate
A. The role of hospital pharmacist in clinical practice with respect to pharmacotherapy
Speaker: Irene Kraemer (Germany)
B. The role of pharmacists in hospital pharmacy practice in the area of pharmacoecomics
Speaker: Lenka Praznovcova (Czech Republic)

Seminar 5, Orphan drug systems in the EU / Level: Intermediate
A. Orphan drug legislation in Europe
Speaker: Veijo Saano (Finland)
B. Ethical and commercial aspects of Orphan Drugs
Speaker: Harrie Seeverens (The Netherlands)

Seminar 7, Information and communication technology and automation of logistics / Level: Advanced
A. System analysis: where to focus with ICT technology
Speaker: Mark Neuenschwander (USA)
B. Practical solutions anno 2005
Speaker: Hadewig Colen (The Netherlands)

Seminar 8, Prescribing drugs: should it always be a medical doctor? / Level: Introductory
A. Legal, ethical and professional aspects of supplementary pharmacy prescribing
Speaker: David Gerrret (United Kingdom)
B. Training for non-doctors prescribers
Speaker: David Webb (United Kingdom)

10.30-11.30: Coffee break and attended posters

11.30-12.30: Keynote presentation
Gaps between innovation and application: translational medicine: the undisciplined heart
Speaker: Eve E. Slater (USA)

12.30-14.00: Closing Ceremony and Lunch